16,935,484 Shares Iovance Biotherapeutics, Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • May 29th, 2020 • Iovance Biotherapeutics, Inc. • Biological products, (no disgnostic substances) • New York
The foregoing will not apply to (i) the registration of the offer and sale of the Shares, and the sale of the Shares to you, in each case as contemplated by the Underwriting Agreement, (ii) the exercise of any option, warrant or other right to acquire shares of common stock of the Company, the settlement of any stock-settled stock appreciation rights, restricted stock or restricted stock units, or the conversion of any convertible security into securities of the Company, provided that any securities received as a result thereof by the undersigned will also be subject to the restrictions in this letter agreement, or (iii) establishment of a trading plan pursuant to Rule 10b5-1 under the Exchange Act for the transfer of Shares, provided that such plan does not provide for any sales or transfers of Shares during the Lock-up Period and the entry into such plan is not publicly disclosed, including in any filing under the Exchange Act, during the Lock-up Period. In addition, the foregoing re
